首页> 外文期刊>Modern Materials Handling >Curing the ills of pharmaceutical DCs - New track-and-trace requirements by organizations ranging from the FDA to Wal-Mart are changing how Pharmaceuticals are moving through the distribution supply chain
【24h】

Curing the ills of pharmaceutical DCs - New track-and-trace requirements by organizations ranging from the FDA to Wal-Mart are changing how Pharmaceuticals are moving through the distribution supply chain

机译:消除药品配送中心的弊端-从FDA到沃尔玛的组织对追踪的新要求正在改变药品在分销供应链中的移动方式

获取原文
获取原文并翻译 | 示例
       

摘要

PHARMACEUTICAL DISTRIBUTORS FACE A variety of challenges as they handle a constantly increasing number and variety of prescription stock keeping units (SKUs). Although these wholesalers often receive large bulk shipments from drug manufacturers, picks tend to be of the broken-case, low-volume variety to fill store, pharmacy, and hospital orders.
机译:药品分销商面临着各种各样的挑战,因为它们要处理数量不断增加且种类繁多的处方库存单位(SKU)。尽管这些批发商通常会从药品制造商那里收到大量散装货物,但拣选往往属于破损,小批量的品种,可以填补商店,药房和医院的订单。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号